Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02958930 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease

A NA study of Alzheimer Disease and Alzheimer Disease, Late Onset, sponsored by NeuroEM Therapeutics.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT02958930 is a NA study of Alzheimer Disease and Alzheimer Disease, Late Onset that has completed, run by NeuroEM Therapeutics. The registered enrollment target is 8 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02958930, a NA study of Alzheimer Disease and Alzheimer Disease, Late Onset, has completed, sponsored by NeuroEM Therapeutics.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the safety and initial efficacy of Transcranial Electromagnetic Treatment (TEMT) in patients with mild/moderate Alzheimer's Disease. Throughout a 2-month treatment period, patients will be evaluated for cognitive performance, brain energy utilization, functional brain imaging, and blood/cerebrospinal fluid (CSF) markers for Alzheimer's Disease. Since all patients will receive TEMT, each patient's baseline measurements will serve as their own control for any treatment effects.

Conditions Studied

Alzheimer Disease Alzheimer Disease, Late Onset

Interventions

  • DEVICE MemorEM 1000

Study Locations (1)

Florida

  • Byrd Alzheimer's Institute, University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2017-10-01
Est. Completion 2019-01-11
Phase NA

Sponsor

NeuroEM Therapeutics

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02958930

The ClinicalTrials.gov registry entry for NCT02958930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The listed sponsor is NeuroEM Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which MemorEM 1000 is the first listed.

NCT02958930 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02958930 about?

NCT02958930 is a clinical study titled "Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease". The purpose of this study is to determine the safety and initial efficacy of Transcranial Electromagnetic Treatment (TEMT) in patients with mild/moderate Alzheimer's Disease. Throughout a 2-month treatment period, patients will be evaluated for cognitive performance, brain energy utilization, functi...

What is the current status of trial NCT02958930?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-10-01. Estimated completion is 2019-01-11.

What conditions does trial NCT02958930 study?

This clinical trial studies the following conditions: Alzheimer Disease, Alzheimer Disease, Late Onset.

What interventions are being tested in trial NCT02958930?

The interventions under investigation include: MemorEM 1000 (DEVICE).

Who is sponsoring clinical trial NCT02958930?

This trial is sponsored by NeuroEM Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02958930 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Alzheimer Disease, Late Onset

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.